Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PAX5 overexpression is not enough to reestablish the mature B-cell phenotype in classical Hodgkin lymphoma.

Literature DB >> 23842424

PAX5 overexpression is not enough to reestablish the mature B-cell phenotype in classical Hodgkin lymphoma.

L Dimitrova¹, V Seitz¹, J Hecht², D Lenze¹, P Hansen³, M Szczepanowski⁴, L Ma⁵, E Oker¹, A Sommerfeld¹, F Jundt⁶, W Klapper⁴, M Hummel¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2013 PMID： 23842424 DOI： 10.1038/leu.2013.211

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

14 in total

1. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin.

Authors: H D Foss; R Reusch; G Demel; G Lenz; I Anagnostopoulos; M Hummel; H Stein
Journal: Blood Date: 1999-11-01 Impact factor: 22.113

Review 2. Epigenetic therapy of cancer: past, present and future.

Authors: Christine B Yoo; Peter A Jones
Journal: Nat Rev Drug Discov Date: 2006-01 Impact factor: 84.694

3. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells.

Authors: Shane McManus; Anja Ebert; Giorgia Salvagiotto; Jasna Medvedovic; Qiong Sun; Ido Tamir; Markus Jaritz; Hiromi Tagoh; Meinrad Busslinger
Journal: EMBO J Date: 2011-05-06 Impact factor: 11.598

Review 4. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.

Authors: B Falini; S Pileri; G Pizzolo; H Dürkop; L Flenghi; F Stirpe; M F Martelli; H Stein
Journal: Blood Date: 1995-01-01 Impact factor: 22.113

5. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis.

Authors: M Horcher; A Souabni; M Busslinger
Journal: Immunity Date: 2001-06 Impact factor: 31.745

6. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling.

Authors: Ralf Küppers; Ulf Klein; Ines Schwering; Verena Distler; Andreas Bräuninger; Giorgio Cattoretti; Yuhai Tu; Gustavo A Stolovitzky; Andrea Califano; Martin-Leo Hansmann; Riccardo Dalla-Favera
Journal: J Clin Invest Date: 2003-02 Impact factor: 14.808

7. Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs.

Authors: Uta E Höpken; Hans-Dieter Foss; Dagmar Meyer; Michael Hinz; Korinna Leder; Harald Stein; Martin Lipp
Journal: Blood Date: 2002-02-15 Impact factor: 22.113

8. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors.

Authors: César Cobaleda; Wolfram Jochum; Meinrad Busslinger
Journal: Nature Date: 2007-09-12 Impact factor: 49.962

9. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.

Authors: V Bohle; C Döring; M-L Hansmann; R Küppers
Journal: Leukemia Date: 2012-10-01 Impact factor: 11.528

10. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.

Authors: Enrico Tiacci; Claudia Döring; Verena Brune; Carel J M van Noesel; Wolfram Klapper; Gunhild Mechtersheimer; Brunangelo Falini; Ralf Küppers; Martin-Leo Hansmann
Journal: Blood Date: 2012-09-05 Impact factor: 22.113

9 in total

1. A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma.

Authors: Maria Joosten; Sebastian Ginzel; Christian Blex; Dmitri Schmidt; Michael Gombert; Cai Chen; René Martin Linka; Olivia Gräbner; Anika Hain; Burkhard Hirsch; Anke Sommerfeld; Anke Seegebarth; Uschi Gruber; Corinna Maneck; Langhui Zhang; Katharina Stenin; Henrik Dieks; Michael Sefkow; Carsten Münk; Claudia D Baldus; Ralf Thiele; Arndt Borkhardt; Michael Hummel; Hubert Köster; Ute Fischer; Mathias Dreger; Volkhard Seitz
Journal: Mol Oncol Date: 2016-06-09 Impact factor: 6.603

2. Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL.

Authors: V Seitz; K Kleo; A Dröge; S Schaper; S Elezkurtaj; N Bedjaoui; L Dimitrova; A Sommerfeld; E Berg; E von der Wall; U Müller; M Joosten; D Lenze; M M Heimesaat; C Baldus; C Zinser; A Cieslak; E Macintyre; C Stocking; S Hennig; M Hummel
Journal: Sci Rep Date: 2020-06-22 Impact factor: 4.379

3. IMPACT: Genomic Annotation of Cell-State-Specific Regulatory Elements Inferred from the Epigenome of Bound Transcription Factors.

Authors: Tiffany Amariuta; Yang Luo; Steven Gazal; Emma E Davenport; Bryce van de Geijn; Kazuyoshi Ishigaki; Harm-Jan Westra; Nikola Teslovich; Yukinori Okada; Kazuhiko Yamamoto; Alkes L Price; Soumya Raychaudhuri
Journal: Am J Hum Genet Date: 2019-04-18 Impact factor: 11.025

4. Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development.

Authors: Fumiya Moribe; Momoko Nishikori; Tsuyoshi Takashima; Daiki Taniyama; Nobuyuki Onishi; Hiroshi Arima; Hiroyuki Sasanuma; Remi Akagawa; Fathi Elloumi; Shunichi Takeda; Yves Pommier; Eiichi Morii; Akifumi Takaori-Kondo; Junko Murai
Journal: PLoS One Date: 2021-01-29 Impact factor: 3.240